Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-08-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm9007104PMID 19658404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo studies of a platinum(II) metallointercalator.

  2008cited by this paper
• Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents.

  2008cited by this paper
• Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione.

  2008cited by this paper
• DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis.

  2007cited by this paper
• Chiral Platinum(II) Metallointercalators with Potent in vitro Cytotoxic Activity

  2007cited by this paper
• Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.

  2007cited by this paper
• Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.

  2007cited by this paper
• The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.

  2007cited by this paper
• Light-activated destruction of cancer cell nuclei by platinum diazide complexes.

  2006cited by this paper
• Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data

  2006cited by this paper
• [1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug‐Target Interaction to the Antitumor Activity

  2004cited by this paper
• DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.

  2004cited by this paper
• [1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level

  2004cited by this paper
• Polynuclear platinum drugs.

  2004cited by this paper
• DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.

  2003cited by this paper
• DNA melting in the presence of fluorescent intercalating oxazole yellow dyes measured with a gel-based assay.

  2002cited by this paper
• Tumor Inhibiting [1,2‐Bis(fluorophenyl)ethylenediamine]platinum(II) Complexes, III1): Evaluation of the Mammary Tumor Inhibiting Properties

  1990cited by this paper
• Differential scanning calorimetric study of the effect of intercalators and other kinds of DNA-binding drugs on the stepwise melting of plasmid DNA.

  1990cited by this paper
• Platinum compounds with estrogen receptor affinity.

  1990cited by this paper
• Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.

  1989cited by this paper
• Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes

  1988cited by this paper
• Activity of platinum(II) intercalating agents against murine leukemia L1210.

  1985cited by this paper
• Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma.

  1984cited by this paper
• Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides.

  1976cited by this paper
• Metallointercalation reagents. 2-hydroxyethanethiolato(2,2',2'-terpyridine)-platinum(II) monocation binds strongly to DNA by intercalation.

  1974cited by this paper

• Biogenic Nickel Oxide Nanoparticles for the Catalytic Reduction of Nitrobenzene Derivatives and Their Anticancer and Antioxidant Activities

  2025cites this paper
• Platinum(II) and ruthenium(II) coordination complexes equipped with an anchoring site for binding the protein kinase enzyme pockets: synthesis, molecular docking and biological assays.

  2025cites this paper
• Noble Metal Complexes in Cancer Therapy: Unlocking Redox Potential for Next-Gen Treatments

  2025cites this paper
• Green Protocol for Design, Synthesis, and Biological Evaluation of New Schiff Base Complexes of Co(II), Ni(II), Zn(II), and Cd(II) Metal Ions

  2025cites this paper
• Antitumor platinum(II) complex 56MESS binds to DNA G-quadruplexes, downregulates expression of c-MYC and k-RAS oncogenes, and triggers DNA damage in cancer cells.

  2025cites this paper
• Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead

  2024cites this paper
• Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity

  2024cites this paper
• What happened to BBR3464 and where to from here for multinuclear platinum-based anticancer drugs?

  2024cites this paper
• Microwave-assisted synthesis, spectral characterization, and biological activities of complexes of a Schiff base derived from S-benzyl dithiocarbazate

  2024cites this paper
• Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

  2023cites this paper
• Platinum(IV) Derivatives of [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)] with Diclofenac Ligands in the Axial Positions: A New Class of Potent Multi-action Agents Exhibiting Selectivity to Cancer Cells

  2023cites this paper
• Potent Chlorambucil-Platinum(IV) Prodrugs

  2022cites this paper
• Novel zinc(II)-curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs.

  2022cites this paper
• Platinum(II) complexes with malonic acids: Synthesis, characterization, in vitro and in vivo antitumor activity and interactions with biomolecules.

  2022cites this paper
• Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates

  2022cites this paper
• Synthesis, characterization, structural studies, DNA interaction, and cytotoxic studies of palladium(II) mixed-ligand complexes containing 2,2′-bipyridine, 5,6-dimethyl-1,10-phenanthroline and tetrazole-5-thiol ligands

  2021cites this paper
• Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs

  2021cites this paper
• Synthesis and antitumor activities of transition metal complexes of a bis-Schiff base of 2-hydroxy-1-naphthalenecarboxaldehyde.

  2020cites this paper
• Platinum Complexes in Medicine and in the Treatment of Cancer

  2020cites this paper
• Exploring the DNA Binding Mechanisms of Platinum-Based Chemotherapeutic Agents: State of Art and Perspectives of the Candidates

  2020cites this paper
• Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands

  2020cites this paper
• Diazido platinum(iv) complexes for photoactivated anticancer chemotherapy

  2019cites this paper
• A Nanobody-Conjugated DNA Nanoplatform for Targeted Platinum Drug Delivery.

  2019cites this paper
• High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives.

  2019cites this paper
• In vitro and in vivo activity of novel platinum(ii) complexes with naphthalene imide derivatives inhibiting human non-small cell lung cancer cells

  2019cites this paper
• New platinum(II)-based DNA intercalator: Synthesis, characterization and anticancer activity

  2019cites this paper
• Azaindoles: Suitable ligands of cytotoxic transition metal complexes.

  2019cites this paper
• Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues.

  2018cites this paper
• Synthesis of a Platinum Triamine Complex and its Interactions with Guanosine 5’- Monophosphate and N-Acetylmethionine

  2018cites this paper
• The interactions of novel mononuclear platinum-based complexes with DNA

  2018cites this paper
• Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.

  2018cites this paper
• Platinum Intercalators of DNA as Anticancer Agents

  2017cites this paper
• Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.

  2017cites this paper
• Chapter Seven – Antimicrobial Metallodrugs

  2017cites this paper
• Platinum coordination compounds with potent anticancer activity

  2017cites this paper
• Research progress in modern structure of platinum complexes.

  2017cites this paper
• SYNTHESIS, CRYSTAL STRUCTURE, SPECTROSCOPIC AND DENSITY FUNCTIONAL MODELLING STUDIES OF THE 2-ISOPROPYLBENZIMIDAZOLIUM TETRACHLOROPLATINATE(II) MONOHYDRATE

  2017cites this paper
• Probing the Interactions of Cytotoxic [Pt(1S,2S‐DACH)(5,6‐dimethyl‐1,10‐phenanthroline)] and Its PtIV Derivatives with Human Serum

  2017cites this paper
• Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(iv) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)].

  2017cites this paper
• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

  2016cites this paper
• Cytotoxicity and cellular response mechanisms of water-soluble platinum(II) complexes of lidocaine and phenylcyanamide derivatives

  2016cites this paper
• Multifaceted Studies of the DNA Interactions and In Vitro Cytotoxicity of Anticancer Polyaromatic Platinum(II) Complexes.

  2016cites this paper
• Synthesis, characterisation and cytotoxicity of [(1,10-phenanthroline)(1R,2R,4R/1S,2S,4S)-4-methyl-1,2-cyclohexanediamine)platinum(II)]2+ (PHEN-4-MeDACH)

  2016cites this paper
• Tuning the structural and photophysical properties of cationic Pt(II) complexes bearing neutral bis(triazolyl)pyridine ligands.

  2015cites this paper
• Synthesis and Analysis of the Structure, Diffusion and Cytotoxicity of Heterocyclic Platinum(IV) Complexes.

  2015cites this paper
• Metal complex interactions with DNA.

  2015cites this paper
• Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.

  2015cites this paper
• Cytotoxicity and Structural Analyses of 2,2′‐Bipyridine‐, 4,4′‐Dimethyl‐2,2′‐bipyr­idine‐ and 2‐(2′‐Pyridyl)quinoxalineplatinum(II) Complexes

  2015cites this paper
• Advances in drug delivery system for platinum agents based combination therapy

  2015cites this paper
• Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.

  2014cites this paper
• A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.

  2014cites this paper
• Topical Cream-Based Dosage Forms of the Macrocyclic Drug Delivery Vehicle Cucurbit[6]uril

  2014cites this paper
• Cytochrome P450 2W1 (CYP2W1) as a novel drug target in colon cancer therapy

  2013cites this paper
• Synthesis, structure and in vitro cytotoxic studies of novel paramagnetic palladium(III) complexes with hematoporphyrin IX.

  2013cites this paper
• Cytotoxic platinum(II) intercalators that incorporate 1R,2R-diaminocyclopentane.

  2013cites this paper
• Targeting and delivery of platinum-based anticancer drugs.

  2013cites this paper
• DNA-based aptamer fails as a simultaneous cancer targeting agent and drug delivery vehicle for a phenanthroline-based platinum(II) complex.

  2013cites this paper
• The DNA binding site specificity and antiproliferative property of ternary Pt(II) and Zn(II) complexes of phenanthroline and N,N'-ethylenediaminediacetic acid.

  2013cites this paper
• Synthesis, characterization, interaction with DNA and cytotoxicity of Pd(II) and Pt(II) complexes containing pyridine carboxylic acid ligands.

  2013cites this paper
• Platinum and Ruthenium Complexes for the Therapy of Breast Cancer Diseases

  2013cites this paper
• Characterisation of the interactions and biological impacts of cisplatin analogues and metallo-drug complexes with DNA

  2013cites this paper
• Structural, spectroscopic and theoretical studies on 3,4,7,8-tetramethyl-1,10-phenantroline complex with picric acid

  2013cites this paper
• Highly selective recognition and ultrasensitive quantification of enantiomers.

  2013cites this paper
• Noncovalent DNA binding of metal complexes

  2013cites this paper
• Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts

  2012cites this paper
• Copper(II) and Palladium(II) Complexes with Cytotoxic and Antibacterial Activity

  2012cites this paper
• Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator

  2012influential citation
• Rhodium(III) and iridium(III) complexes as anticancer agents

  2012cites this paper
• Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity?

  2012cites this paper
• Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents.

  2012cites this paper
• Spectroscopic investigations on the interactions of potent platinum(II) anticancer agents with bovine serum albumin

  2012cites this paper
• Comparative analyses of cytotoxicity and molecular mechanisms between platinum metallointercalators and cisplatin.

  2012cites this paper
• Covalent Modification that Enhances Protein Properties and Functions and Folds Random Coil into Alpha-Helix

  2012cites this paper
• Anticancer activity and mode of action of titanocene C

  2011cites this paper
• Uptake and Distribution of a Platinum(II)-Carborane Complex Within a Tumour Cell Using Synchrotron XRF Imaging

  2011cites this paper
• New Trends and Future Developments of Platinum‐Based Antitumor Drugs

  2011cites this paper
• Synthesis, characterization, antitumor and antimicrobial activities of heterocyclic transition metal complexes

  2011influential citation
• The Synthesis of Platinum(II) Intercalators

  2011cites this paper
• Cytotoxicity Testing: Cell Experiments

  2011cites this paper
• Structure-activity screening of platinum intercalators and molecular mechanisms for the cytotoxicity of 56MESS - [Pt(5,6-Dimethyl-Phen)(1S,2S-DACH)]²⁺

  2011cites this paper
• Transition metal based anticancer drugs.

  2011cites this paper
• Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator

  2011cites this paper
• Cellular Selectivity and Biological Impact of Cytotoxic Rhodium(III) and Iridium(III) Complexes Containing Methyl‐Substituted Phenanthroline Ligands

  2011cites this paper
• A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers.

  2011cites this paper
• Synthesis and DNA-binding properties of apoptosis-inducing cytotoxic half-sandwich rhodium(III) complexes with methyl-substituted polypyridyl ligands

  2011cites this paper
• Inhibition of mitogen-activated protein kinase (MAPK) and cyclin-dependent kinase 2 (Cdk2) by platinum(II) phenanthroline complexes

  2011cites this paper
• Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)].

  2011cites this paper
• Determination of concentration and enantiomeric excess of amines and amino alcohols with a chiral nickel(II) complex.

  2011cites this paper
• Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.

  2011cites this paper
• Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.

  2011cites this paper
• Recent researches in metal supramolecular complexes as anticancer agents.

  2010cites this paper
• Interaction of metal complexes with nucleic acids

  2010cites this paper
• Advances in platinum chemotherapeutics.

  2010cites this paper
• 1,10-Phenanthroline: a versatile building block for the construction of ligands for various purposes

  2010cites this paper